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Antimicrobial resistance trends of 
Staphylococcus aureus isolated from 
bovine intramammary infections from 
1990 to the present time in Argentina 
Staphylococcus aureus is one of the most 
prevalent major mastitis pathogens in dairy 
herds worldwide [1]. Antimicrobial therapy 
is one of the bases of S. aureus mastitis 
control programmes, both for subclinical 
cases at drying off and clinical cases 
during lactation [1]. However, cure rates 
following antibiotic therapy are variable 
since several factors associated with 
host, pathogen and treatment regimen 
affect the probability of cure of S. aureus 
intramammary infection (IMI) [2]. Among 
pathogen factors, antibiotic resistance is 
an obvious reason for treatment failure, 
although selection of antibiotics based 
on in vitro susceptibility testing does not 
assure therapeutic success [3]. Despite 
this drawback, most authors agree that 
antibiotic susceptibility testing should 
precede antibiotic treatment, mainly 
in case of subclinical mastitis [2]. In 
addition, antimicrobial susceptibility 
testing is important for monitoring 
the spread of resistant strains among 
bacterial populations. Both determination 
of minimum inhibitory concentration 
(MIC) and disk diffusion test (DD), which 
is the most widely applied method in 
routine veterinary laboratories due to its 
simplicity and low cost, have been used 
for performing antimicrobial susceptibility 
surveys worldwide [4, 5]
The aim of this study was to review 
published research in Argentina on 
antimicrobial susceptibility of S. aureus 
isolated from bovine IMI. Searching for 
the survey included the words “mastitis”, 
“bovine”, “Staphylococcus aureus”, 
“coagulase-positive Staphylococcus”, 
“antimicrobial” “susceptibility” and 
“resistance”. Since previous reports 
indicated that the majority of coagulase-
positive Staphylococci isolated from 
bovine milk are S. aureus [1] studies 
which characterized the isolates either 
as S. aureus or coagulase-positive 
Staphylococci were considered. 
The inclusion criteria were: studies 
performed in Argentina which evaluated 
antimicrobial susceptibility of S. aureus 
isolated from mammary secretion quarter 
and composite samples of cows with 
subclinical and clinical mastitis using MIC 
determination or DD test published in 
peer reviewed journals. Scopus, PubMed, 
and Academic Google databases were 
searched for scientific papers unrestricted 
by language and published from 1990 to 
2018. A total of nine scientific publications 
which reported antimicrobial susceptibility 
of S. aureus isolated from bovine mastitis 
in Argentina is included (Table 1). Only 
those antibiotics included in at least three 
studies are shown in the table. 
DISCUSSION
There is a growing concern about overuse 
and misuse of antimicrobial products for 
treating and preventing infectious diseases 
in cattle due to its contribution to the 
emergence and spread of antimicrobial 
resistant organisms. These organisms 
represent a great threat to human and 
animal health, and to the world ecosystem 
[15]. Bovine mastitis is the most frequent 
reason for treating both lactating and non-
lactating dairy cattle [16, 17] There are no 
studies in Argentina and limited studies 
worldwide which compare resistance 
patterns before and after antibiotic 
usage throughout years using consistent 
procedures to evaluate the emergence 
of resistance due to antibiotic usage [16]. 
However, several studies have described 
occurrence of S. aureus resistance to 
antibiotics over time [5]. The antibiotics 
that were more consistently evaluated 
in Argentina were the beta-lactams and 
those of the macrolide-lyncosamide class. 
Penicillin is considered a first choice 
antibiotic for treating bovine mastitis. 
Resistance to penicillin has varied among 
studies showing the highest percentages 
during the first two decades (1990–
2000) and lower percentages in studies 
conducted in the current decade. Only in 
one study, published in 2001, oxacillin-
resistant coagulase-positive Staphylococci 
were detected, indicating that it could 
have been an isolated finding. However, 
since methicillin-resistant S. aureus have 
been detected in several countries [18], 
continuous surveillance is needed for early 
detection of emergence of this type of 
resistance.
Antibiotics from macrolide-lyncosamide 
class are frequently used in Argentina for 
treating bovine mastitis [17]. Erythromycin 
is the most commonly tested macrolide 
as representative of this group, using 
approved human interpretive criteria [19]. 
Resistance to erythromycin was low in 
most studies. Only in one study in the 
last decade did it exceed 20%, which is 
higher than percentages reported both in 
Argentina and other countries [5]. Pirlimycin 
was commercially available in Argentina 
during the 90s, and has recently been 
introduced again to the veterinary market. 
Susceptibility to this antibiotic was reported 
in studies published at the beginning of 
the 2000 decade using veterinary-specific 
interpretive criteria [19], showing variable 
resistance among studies and percentages 
comparable with previous reports in other 
countries [5]. 
In conclusion, although information is 
limited, there is no apparent emergence or 
progression of S. aureus resistance to the 
most commonly used antibiotics for treating 
bovine mastitis in Argentina. This finding 
is in accord with previous reports which 
included studies conducted in different 
countries [5, 16]. However, there is a need 
to extend these studies to other bovine 
mastitis pathogens, using a harmonized 
approach to allow measuring resistance 
trends over time [15]. This information, 
together with increasing knowledge about 
antibiotic usage in dairy farms in Argentina 
[17] will allow us to evaluate and propose 
actions for a more responsible and prudent 
use of antibiotics in our dairy farms.
2018 IDF Animal Health Report • Issue N°1228
I. Molineri Ana1, 2, V. Neder1, 
L. F. Calvinho1, 3
1Estación Experimental Agropecuaria 
Rafaela, Argentina, 2Consejo Nacional 
de Investigaciones Científicas y 
Tecnológicas, Argentina 3Universidad 
Nacional del Litoral,  argentina 
calvinho.luis@inta.gob.ar
REFERENCES
1. Barkema, H.W., Schukken, Y.H. & Zadoks, R.N. 
(2006) The role of cow, pathogen, and treatment 
regimen in the therapeutic success of bovine 
Staphylococcus aureus mastitis. J. Dairy Sci. 
89:1877–1895
2. Calvinho, L.F., Vitulich, C.A., Zurbriggen, M.A., de 
Canavesio, V., Tarabla, H.D. (1991a) Prevalence of 
udder pathogens in dairy herds from the Santa Fe 
dairy area (In Spanish). Therios 18:188–96.
3. Calvinho, L.F., Delgado, A.R., Vitulich, C.A., Oc-
chi, H.L., de Canavesio, V., Zurbriggen, M.A., 
Tarabla, H.D. (1991b) In vitro susceptibility to 
antimicrobials of udder pathogens isolated from 
clínicas mastitis from dairy herds of Santa Fe dairy 
área. (In Spanish) Vet. Arg. 8:677–680.
4. Calvinho, L.F., Toselli, F.G., Weinmann, W.R., 
Canavesio, V.R., Neder, V.E., Igusquiza, I.A. (2002) 
Antimicrobial susceptibility of coagulase-posi-
tive Staphylococcus isolated from bovine mastitis 
in the Central dairy area of Argentina. (In Spanish). 
Rev. Arg. Microbiol. 34:171–175.
5. CLSI (Clinical and Laboratory Standards Institute). 
(2013) Performance standards for antimicrobial 
disk and dilution susceptibility tests for bacteria 
isolated from animals. Clinical Laboratory Stand-
ards Institute, Wayne, PA, USA. 2013; Vol. 28, No. 
8. 4th ed. Approved standard, VET01-A4.
6. Erskine, R.J., Walker, R.D., Bolin, C.A., Barlett, 
P.C., White, D.G. (2002) Trends in antibacterial 
susceptibility of mastitis pathogens during a sev-
en-year period. J. Dairy Sci. 85:1111–1118
7. Erskine, R., Cullor, J., Schaellibaum, M., Yancey, 
B., Zecconi, A. (2004) Bovine mastitis pathogens 
and trends in resistance to antibacterial drugs. 
National Mastitis Council Research Committee 
Report. In: NMC Annual Meeting Proceedings. 
Pg. 400–414.
8. Gentilini, E., Denamiel, G., Llorente, P., Godaly, S., 
Rebuelto, M., DeGregorio, O. (2000) Antimicrobial 
Susceptibility of Staphylococcus aureus Isolat-
ed from Bovine Mastitis in Argentina. J Dairy Sci 
83:1224–1227
9. González Pereyra, V., Pol, M., Pastorino, F., Herre-
ro, A. (2015) Quantification of antimicrobial usage 
in dairy cows and preweaned calves in Argentina. 
Prev. Vet. Med. 122:273–279.
10. Hoe, F.G., Ruegg, P.L. (2005) Relationship be-
tween antimicrobial susceptibility of clinical mas-
titis pathogens and treatment outcome in cows. 
J.A.V. M. A. 227:1461–1468
11. Huber, H., Koller, S., Giezendanner, N., Stephan, 
R., Zweifel. C. (2010) Prevalence and characteris-
tics of meticillin-resistant Staphylococcus aureus 
in humans in contact with farm animals, in live-
stock, and in food of animal origin, Switzerland, 
2009. Euro Surveill. 2010;15:1–4.
12. Micheo, C., Amand de Mendieta, V., Soriano, C., 
Tabera, A., Stefano, A., Casasnovas, G., Purrán, 
P., Corradeti, A., Carabajal, S. (2001) Study of in 
vitro susceptibility of bacterial strains isolated 
from bovine mastitis in Mar y Sierras dairy area. (In 
Antibiotic % Resistant
Penicillin 14.81 77.5 55.89 40.3 47.6 48.4 14.3 28.12 33.85
Oxacillin - - 2.94 0 0 0 - 0 0
Erythromycin - - 5.6 11.6 2 2.1 22.2 3.12 7.69
Pirlimycin - - 14.71 7.7 4 - - - -
N 33 79 34 206 101 95 63 96 65
Reference 1 2 3 4 5 6 7 8 9
Table 1 – Antimicrobial resistance of Staphylococcus aureus isolated from bovine mastitis in Argentina ([6, 7, 8, 9, 10, 11, 12, 13, 14].
Spanish). Vet. Arg. 18:588–597.
13. Neder, V.E., Araujo, L., Gianre, V.R., Calvinho, L.F. 
(2016) Antibiotic susceptibility of Staphylococ-
cus aureus isolated from bovine mastitis in dairy 
farms from the central dairy area of Argentina (In 
Spanish). REDVET Rev. Electrón. vet. Vol. 17 Nº 
9 - http://www.veterinaria.org/revistas/redvet/n09 
0916.html
14. Office International des Épizooties. (2016) The OIE 
Strategy on Antimicrobial Resistance and the Pru-
dent Use of Antimicrobials. www.oie.int/antimicro-
bial-resistance.
15. Oliver, S.P., Murinda, S.E. (2012) Antimicrobial 
resistance of mastitis pathogens. Vet. Clin. Food 
Anim.28:165–185.
16. Pellegrino, M.S., Frola, I.D., Odierno, L.M., 
Bogni, C.I. (2011) Mastitis bovina: resistencia 
a antibióticos de cepas de Staphylococcus au-
reus aisladas de leche. (In Spanish). REDVET Rev. 
electrón. vet. http://www.veterinaria.org/revistas/red- 
vet Volumen 12 Nº 7 - http://www.veterinaria.org/
revistas/redvet/n070711.html
17. Russi, N.B., Bantar, C., Calvinho, L.F. (2008) An-
timicrobial susceptibility of Staphylococcus au-
reus causing bovine mastitis in Argentine dairy 
herds. Rev. Arg. Microbiol. 40:116–119.
18. Srednik, M.E., Abate, S., Gentilini, E.R. (2016) 
Antibiotic susceptibility of Staphylococci isolated 
from milk samples obtained from bovine mastitis 
(In Spanish). In Vet. 18:39–44.
19. Zecconi, A., Calvinho, L., Fox, L. (2006) Staphylo-
coccus aureus intramammary infections. Bulletin 
of the International Dairy Federation. 408/2006. 
Pp 39. FIL-IDF. ISSN 0250–5118
29Research
